CLINICAL_TRIALS
trial_result
· 2018-11-16
Clinical Trial Update: Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients [Phase 3]
Summary
Phase 3 trial update on G-Pen glucagon injection for pediatric type 1 diabetes; results completed and posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xeris Pharmaceuticals | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2018-11-16